Table 16Clinical heterogeneity variables specified in key questions for AHRQ comparative effectiveness reviews
CER Topic | Key Question and Specific Clinical Heterogeneity Variables |
---|---|
Comparative Effectiveness of Drug Therapy for Rheumatoid Arthritis and Psoriatic Arthritis in Adults | KQ 4. What are the comparative benefits and harms of drug therapies for rheumatoid arthritis and psoriatic arthritis in subgroups of patients based on stage of disease, history of prior therapy, demographics, concomitant therapies, or comorbidities? |
Comparative Effectiveness of Percutaneous Coronary Bypass Grafting for Coronary Artery Diseases | KQ 2. Is there evidence that the comparative effectiveness of PCI and CABG varies based on:
|
Comparative Effectiveness of Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression | KQ 3. Do medications or combinations of medications (including tricyclics in combination) used to treat depression differ in their efficacy or effectiveness for treating accompanying symptoms, such as anxiety, insomnia, and neurovegetative symptoms?
|
CABG=coronary artery bypass grafting; PCI=percutaneous coronary intervention.
- Table 16, Clinical heterogeneity variables specified in key questions for AHRQ c...Table 16, Clinical heterogeneity variables specified in key questions for AHRQ comparative effectiveness reviews - Comparative Effectiveness Review Methods: Clinical Heterogeneity
Your browsing activity is empty.
Activity recording is turned off.
See more...